AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Protagonist Therapeutics, Inc.

$144.85 +$57.67 (+66.15%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$144.34
Day Range
$142.54$146.00
Year Range
$75.44$160.81
Market Cap
9.37B
AVG Volume
683.37K
Trailing/Forward PE
118.91/-
PEG ratio
-0.35
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PTGX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2281.99M
26 Q174.06M
25 Q446.02M
25 Q3209.22M
25 Q2209.18M
25 Q1207.8M
24 Q4434.43M
24 Q3323.8M
24 Q2319.12M
24 Q1314.95M
Net Income (USD) · TTM
-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PTGX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q282.91M
26 Q1-114.71M
25 Q4-130.15M
25 Q345.91M
25 Q252.04M
25 Q156.19M
24 Q4275.19M
24 Q3170.85M
24 Q2169.95M
24 Q1162.11M
Operating Income (USD) · TTM
-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PTGX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q258.34M
26 Q1-142.47M
25 Q4-158.13M
25 Q319.01M
25 Q223.98M
25 Q127.22M
24 Q4252.84M
24 Q3149.11M
24 Q2152.24M
24 Q1148.68M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PTGX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Protagonist Therapeutics, Inc.
PTGX
Stockpicker

Video analysis: PTGX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PTGX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.